Stocks · News reference
This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Consider ACMR stock: analysts' thoughts
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — ACM Research, Inc. (ACMR)
Filed: 2026-09-30 AccNo: 0001628280-26-063896 Size: 157 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Shares of semiconductor companies are trading higher amid overall market strength and easing inflation concerns as investors return to AI-related companies.
Shares of semiconductor and chip-related companies are trading lower after AI executives signaled that the industry's growth may need to be slowed. The industry is also facing pressure as oil prices spike in reaction to the escalating conflict in the Middle East which can lead to inflation, tighter lending and reduced demand.
UBS Initiates Coverage On Evommune with Neutral Rating, Announces Price Target of $8
UBS analyst Alice Nettleton initiates coverage on Evommune (NYSE:EVMN) with a Neutral rating and announces Price Target of $8.
Evommune Presents Additional Data From Phase 2a Proof-Of-Concept Trial Of EVO301 In Adults With Atopic Dermatitis At EADV 2026 Congress; Plan To Initiate Subcutaneous Phase 2b Dose-Ranging Trial In Mid-2027